Dr. Hervé Maisonneuve is an original figure in the scientific edition. Consultant in medical publishing, author of the blog Medical and scientific writing, past both by the pharmaceutical industry and the world of public research, staunch defender of scientific integrity, he is a keen connoisseur of the cogs of this often opaque universe for the general public. He agreed to share his vision of “LancetGate” with us, and the flaws that this case reveals in the production of biomedical knowledge. “I am 70 years old and I am out of university which allows me to say things”, he tells us at the start of the interview. Of which act.
Recall of facts. On May 22, a large observational study, carried out by American researchers and published in the prestigious Lancet, alert on the association between hydroxychloroquine and excess mortality in Covid-19 patients treated in hospital. The repercussions are major, and many clinical trials around the world are interrupted while checking for the absence of toxicity. But critics are quickly heard on the reliability of the patient data analyzed, from 671 hospitals worldwide and collected by an American startup.
Read “The“ LancetGate ”, media account of a scientific scandal”
Under the leadership of Didier Raoult, the case was nicknamed, rightly or wrongly, “LancetGate”. On June 5, before the impossibility of accessing the complete data, three of the authors requested the withdrawal of the article. Investigations of the fourth author, the entrepreneur behind the data collection, report questionable practices.
This article is for subscribers only.
Log in
–
Access all of our content, support independent writing.
Subscribe
–
–
–
–
–
The newsletter which addresses the challenges of emerging from the crisis according to a different theme
–
–